Rates of syphilis in most high income nations have been steadily increasing since 2000, but that increase has accelerated since 2010, rising 56-130% over the last 5 years in the U.S., U.K. Germany, France, and Australia. In all of these areas, syphilis predominately affects men who have sex with men (MSM), particularly HIV-infected MSM. However, some evidence suggests that the syphilis epidemic is now expanding to include HIV-negative MSM without risk factors such as methamphetamine use, and in some areas, rates are now rising among women, with an associated risk of increasing congenital syphilis. Factors contributing to the rise in syphilis include the integrated effects of widespread and effective HIV treatment, HIV pre-exposure prophylaxis (PrEP), and geosocial apps, which together facilitate condomless sex guided by diverse seroadaptive behaviors. The rise of syphilis poses challenges for clinicians as they confront increasing numbers of cases of neuro-, ocular- and otosyphilis, and dilemmas related to performing lumbar punctures and interpreting syphilis serologies in patients tested at increasing frequency. The syphilis epidemic represents a public health challenge, but it also presents opportunities. There is an urgent need to control syphilis, to mitigate the morbidity of the infection and its spread, particularly to women, while capitalizing on the diagnosis of syphilis to promote frequent testing for HIV and other sexually transmitted infections, viral suppression among HIV-infected persons, PrEP use, and condoms. This presentation will review the current epidemiology of syphilis and factors contributing to the ongoing syphilis epidemic; key clinical issues in the management of syphilis; and the public health implications of rising syphilis rates.